Outcome and prognostic factors in 110 consecutive patients with primary uterine leiomyosarcoma:A Rare Cancer Network study

被引:1
|
作者
Alessandra Franzetti Pellanda [1 ,2 ]
Berardino De Bari [1 ,3 ]
Elisabeth Deniaud-Alexandre [4 ,5 ]
Marco Krengli [6 ]
Paul Van Houtte [7 ]
Antonella Richetti [8 ,9 ]
Salvador Villà [10 ]
Hadassah Goldberg [11 ]
Ewa Szutowicz-Zielińska [12 ]
Michel Bolla [13 ]
Heidi Rutten [14 ]
Marc Van Eijkeren [15 ]
Philip Poortmans [14 ,16 ]
Guido Henke [17 ]
Yavuz Anacak [18 ]
Steve Chan [19 ]
Christine Landmann [20 ]
Carine Kirkove [21 ]
Luciano Scandolaro [22 ]
Jacques Bernier [23 ,24 ]
René-Olivier Mirimanoff [1 ]
Mahmut Ozsahin [1 ]
机构
[1] Centre Hospitalier Universitaire Vaudois (CHUV)
[2] Clinica Luganese Moncucco  3. Centre Hospitalier Régional Universitaire “Jean Minjoz”,INSERM
[3] H?pital Tenon
[4] Centre Hospitalier Départemental
[5] Università degli Studi del Piemonte Orientale e Ospedale Maggiore della Carità
[6] Institut Jules Bordet  8. Ospedale di Circolo  9. Istituto Oncologico della Svizzera Italiana,EOC 
关键词
Uterine leiomyosarcoma; prognostic factors; radiotherapy; overall survival; local control;
D O I
暂无
中图分类号
R737.33 [子宫肿瘤];
学科分类号
摘要
Objective: Primary uterine leiomyosarcomas(ULMS) are rare,and the optimal treatment is controversial.We aimed to assess the outcome and prognostic factors in a multicenter population of women treated for primary ULMS.Methods: We retrospectively collected data of 110 women treated in 19 institutions of the Rare Cancer Network(RCN).Inclusion criteria consisted of a pathology report confirming the diagnosis of ULMS,aged 18–80 years,complete International Federation of Gynecology and Obstetrics(FIGO) stage information,complete information on treatment,and a minimum follow-up of 6 months.Local control(LC) and locoregional control(LRC),overall survival(OS) and disease-free survival(DFS) rates were computed using the Kaplan-Meier method.Univariate analysis was implemented using the log rank test,and multivariate analysis using the Cox model.Results: All patients underwent surgery.Seventy-five patients(68%) received adjuvant radiotherapy(RT),including brachytherapy in 18(16%).Seventeen patients(15%) received adjuvant chemotherapy.Median follow-up was 58(range,6–240) months.Five-year OS and DFS rates were 50% and 34%,and LC and LRC rates were 88%and 72%,respectively.On multivariate analysis,independent favorable prognostic factors were younger age,FIGO stage I,small tumor size,previous uterine disease,and no vascular invasion for OS and DFS.FIGO stage was the only favorable factor influencing LRC.Adjuvant local or systemic treatments did not improve the outcomes.Eight patients treated with RT presented a grade 3 acute toxicity,and only one patient with grade 3 late toxicity.Conclusions: In this large population of primary ULMS patients,we found good results in terms of LC and LRC.Nevertheless,OS remains poor,mainly due to the occurrence of distant metastases.An early diagnosis seemed to improve the prognosis of the patients.Adjuvant local or systemic treatments,or more aggressive surgicalprocedures such as the Wertheim procedure,did not seem to impact the outcome.
引用
收藏
页码:521 / 532
页数:12
相关论文
共 50 条
  • [31] Prognostic factors in leiomyosarcoma (LMS): Does primary site influence outcome?
    Rashid, M. F. R. Harunal
    Ong, W. S.
    Teo, M.
    Tan, M. H.
    Foo, L. S. S.
    Lim, Y. K.
    Chin, F.
    Lee, M. J. F.
    Ho, Z. C.
    Jeevan, R.
    Chia, J. W. K.
    Soh, L.
    Poon, D.
    Quek, R. H. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [32] Survival and prognostic factors in patients undergoing parenchymal saving bronchoplastic operation for primary lung cancer: a series of 110 consecutive cases
    Icard, P
    Regnard, JF
    Guibert, L
    Magdeleinat, P
    Jauffret, B
    Levasseur, P
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1999, 15 (04) : 426 - 432
  • [33] Outcomes and Prognostic Factors for a Consecutive Case Series of 115 Patients with Somatic Leiomyosarcoma
    Abraham, John A.
    Weaver, Michael J.
    Hornick, Jason L.
    Zurakowski, David
    Ready, John E.
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2012, 94A (08): : 736 - 744
  • [34] Atypical and malignant meningioma: Outcome and prognostic factors in 119 irradiated patients. A multicentre, retrospective study of the rare cancer network
    Rezvoy, N.
    Bijmolt, S.
    Villa, S.
    Krengli, M.
    Weber, D.
    Baumert, B.
    Canyilmaz, E.
    Yalman, D.
    Szutowicz, E.
    Tzuk-Shina, T.
    EJC SUPPLEMENTS, 2007, 5 (04): : 227 - 227
  • [35] Atypical and malignant meningioma: Outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network
    Pasquier, David
    Bijmolt, Stefan
    Veninga, Theo
    Rezvoy, Nicolas
    Villa, Salvador
    Krengli, Marco
    Weber, Damien C.
    Baumert, Brigitta G.
    Canyilmaz, Emine
    Yalman, Deniz
    Szutowicz, Ewa
    Tzuk-Shina, Tzahala
    Mirimanoff, Rene O.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (05): : 1388 - 1393
  • [36] Outcome and prognostic factors in cerebellar glioblastoma multiforme in adults:: A retrospective study from the rare cancer network
    Weber, Damien C.
    Miller, Robert C.
    Villa, Salvador
    Hanssens, Patrick
    Baumert, Brigitta G.
    Castadot, Pierre
    Varlet, Pascale
    Abacioglu, Ufuk
    Igdem, Sefik
    Szutowicz, Ewa
    Nishioka, Hiroshi
    Hofer, Silvia
    Rutz, Hans Peter
    Ozsahin, Mahmut
    Taghian, Alphonse
    Mirimanoff, Rene O.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (01): : 179 - 186
  • [37] Outcome and prognostic factors in cerebellar glioblastoma multiforme in adults:: A retrospective study from the rare cancer network
    Weber, D. C.
    Miller, R. C.
    Taghian, A.
    Hanssens, P.
    Villa, S.
    Ozsahin, M.
    Mirimanoff, R. O.
    Nishioka, H.
    Castadot, P.
    Rutz, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S252 - S252
  • [38] Prognostic Factors and Survival in Patients Treated Surgically for Recurrent Metastatic Uterine Leiomyosarcoma
    Hoang, Han L. T.
    Ensor, Kelsey
    Rosen, Gerald
    Pachter, H. Leon
    Raccuia, Joseph S.
    INTERNATIONAL JOURNAL OF SURGICAL ONCOLOGY, 2014, 2014
  • [39] PROGNOSTIC FACTORS AND TREATMENT OUTCOMES OF PATIENTS WITH UTERINE LEIOMYOSARCOMA: A RETROSPECTIVE STUDY OF ANATOLIAN SOCIETY OF MEDICAL ONCOLOGY
    Durnali, A.
    Tokluoglu, S.
    Ozdemir, N.
    Inanc, M.
    Alkis, N.
    Zengin, N.
    Sonmez, O. U.
    Kucukoner, M.
    Ozkan, M.
    Oksuzoglu, B.
    ANNALS OF ONCOLOGY, 2012, 23 : 332 - 333
  • [40] PROGNOSTIC ROLE OF PLASMA FIBRINOGEN IN PATIENTS WITH UTERINE LEIOMYOSARCOMA - A MULTICENTER STUDY
    Bekos, C.
    Petru, E.
    Hefler, L.
    Reimer, D.
    Koch, H.
    Polterauer, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 235 - 235